Inpharma Weekly

, Volume 1330, Issue 1, pp 18–18 | Cite as

Alemtuzumab reduces mortality and morbidity following unrelated donor stem cell transplantation

Clinical study

Keywords

Melphalan Haematological Malignancy Evaluable Patient Fludarabine Alemtuzumab 

Copyright information

© Adis International Ltd 2002

Personalised recommendations